this was achieved by a convergence of tools : designing ria with antibodies to each of these domains , including antibodies to dyn-a17 , dyn-b , alpha-neo-endorphin , bridge peptide , and pro-dyn carboxyl-terminal peptide ( c-peptide ) , and using these antisera with gel filtration chromatography , reverse phase hplc , immunoaffinity , and immunoprecipitation techniques .
C0003241
antibodies
C0020960
antisera